Recent Finacing
Recent Raise
Ryvu Therapeutics is a Krakow-based clinical-stage drug discovery and development company creating small-molecule oncology therapies, progressing CDK8/19 inhibitor RVU120 in Phase II and partnering with BioNTech and Exelixis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
